Efficacy of interferon (conventional, pegylated) and lamivudine for treatment of chronic hepatitis B: A systematic review

Machine translation Machine translation
类别 Systematic review
期刊Cadernos de saúde pública / Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública
Year 2009
Loading references information
慢性乙型肝炎被认为是一个重大的公共卫生问题,其治疗需要增加与统一全国卫生系统覆盖成本高昂的药物保健预算开支。这项研究的目的是比较干扰素(传统疗效;聚乙二醇 - PEG2a)和拉米夫定对慢性乙型肝炎的治疗(林)通过系统的审查,选择随机,对照临床试验中医学和紫丁香鉴定。目标成果是病毒学,生化,病理反应,血清转换,以及不利的影响。审查选定的35条。存在或HBeAg和治疗前丙氨酸转氨酶(ALT)水平的情况下被认为是最初的治疗适应症的重要因素。与传统的干扰素治疗可持久的疾病,可导致灭活乙肝表面抗原转阴。 PEG2a均优于干扰素和林和类似的副作用干扰素疗效。林如介绍其在HBeAg阴性的表型敏感性的优势,而它的主要缺点是发展的阻力。
Epistemonikos ID: f5e752ffa385a72abb9e335296c65d0b50a7316a
First added on: Jun 08, 2011
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use